|
|
||||||||
Protein Science, Vol 1, Issue 1 151-160, Copyright © 1992 by Cold Spring Harbor Laboratory Press
ARTICLE |
R. A. DELA-CADENA and R. W. COLMAN
Thrombosis Research Center
The histidine-glycine-rich region of the light chain of cleaved high molecular weight kininogen (HK) is thought to be responsible for binding to negatively charged surfaces and initiation of the intrinsic coagulation, fibrinolytic, and kinin-forming systems. However, the specifically required amino acid sequences have not been delineated. An IgG fraction of a monoclonal antibody (MAb) C11C1 to the HK light chain was shown to inhibit by 66% the coagulant activity and by 57% the binding of HK to the anionic surface of kaolin at a concentration of 1.5 {mu}M and 27 {mu}M, respectively. Proteolytic fragments of HK were produced by successive digestion with human plasma kallikrein and factor XIa (FXIa). Those polypeptides that bound tightly (K(d) = 0.77 nM) to a C11C1 affinity column were eluted at pH 3.0 and purified by membrane filtration. On 15% SDS polyacrylamide electrophoresis, the approximate M(r) was 7.3 kDa (range 6.2-8.1 kDa). Based on N-terminal sequencing, this polypeptide (l(2)), which extends from the histidine residue 459 to a lysine at position 505, 509, 511, 512, 515, or 520, inhibits by 50% the coagulant activity expressed by HK at a concentration of 22 {mu}M. The synthetic peptide HGLGHGH representing the N-terminal of the l(2) fragment was synthesized, tested, and found at 4 mM to inhibit the procoagulant activity of HK 50%. A synthetic heptadecapeptide, HGLGHGHEQQHGLGHGH (residues 459-475) included within the l(2) fragment, and with the ability to bind zinc, inhibited 50% of the HK coagulant activity at a concentration of 325 {mu}M in the absence and presence of added Zn(2+) (30 {mu}M). The specific binding of (125)I-HK to a negatively charged surface (kaolin) was inhibited 50% by unlabeled HK (5 {mu}M). HGLGHGH, at a concentration of 7.0 mM, inhibited the binding to kaolin by 50%. The heptadecapeptide inhibited the specific binding of (125)I-HK to kaolin by 50%, at a concentration of 2.3 mM, in the absence of Zn(2+). In contrast, when Zn(2+) was added, the concentration to achieve 50% inhibition decreased to 630 {mu}M, indicating that Zn(2+) was required to attain a favorable conformation for binding. Moreover, the l(2) fragment was found to inhibit 50% of the (125)I-HK binding to kaolin at a concentration of 380 {mu}M. These results suggest that residues contained within the l(2) fragment, notably NGLGHGHEQQHGLGHGH, serves as a primary structural feature for binding to a negatively charged surface.
This article has been cited by other articles:
![]() |
M. M. Khan, H. N. Bradford, I. Isordia-Salas, Y. Liu, Y. Wu, R. G. Espinola, B. Ghebrehiwet, and R. W. Colman High-Molecular-Weight Kininogen Fragments Stimulate the Secretion of Cytokines and Chemokines Through uPAR, Mac-1, and gC1qR in Monocytes Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2260 - 2266. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Nordahl, V. Rydengard, M. Morgelin, and A. Schmidtchen Domain 5 of High Molecular Weight Kininogen Is Antibacterial J. Biol. Chem., October 14, 2005; 280(41): 34832 - 34839. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kato, T. Okayama, H. Isawa, M. Yuda, Y. Chinzei, and S. Iwanaga Contribution of the N-Terminal and C-Terminal Domains of Haemaphysalin to Inhibition of Activation of Plasma Kallikrein-Kinin System J. Biochem., September 1, 2005; 138(3): 225 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Song, I. M. Sainz, S. C. Cosenza, I. Isordia-Salas, A. Bior, H. N. Bradford, Y.-L. Guo, R. A. Pixley, E. P. Reddy, and R. W. Colman Inhibition of tumor angiogenesis in vivo by a monoclonal antibody targeted to domain 5 of high molecular weight kininogen Blood, October 1, 2004; 104(7): 2065 - 2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Espinola, A. Uknis, I. M. Sainz, I. Isordia-Salas, R. Pixley, R. DeLa Cadena, W. Long, A. Agelan, J. Gaughan, A. Adam, et al. A Monoclonal Antibody to High-Molecular Weight Kininogen Is Therapeutic in a Rodent Model of Reactive Arthritis Am. J. Pathol., September 1, 2004; 165(3): 969 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chavakis, R. A. Pixley, I. Isordia-Salas, R. W. Colman, and K. T. Preissner A Novel Antithrombotic Role for High Molecular Weight Kininogen as Inhibitor of Plasminogen Activator Inhibitor-1 Function J. Biol. Chem., August 30, 2002; 277(36): 32677 - 32682. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Isawa, M. Yuda, Y. Orito, and Y. Chinzei A Mosquito Salivary Protein Inhibits Activation of the Plasma Contact System by Binding to Factor XII and High Molecular Weight Kininogen J. Biol. Chem., July 26, 2002; 277(31): 27651 - 27658. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chavakis, N. Boeckel, S. Santoso, R. Voss, I. Isordia-Salas, R. A. Pixley, E. Morgenstern, R. W. Colman, and K. T. Preissner Inhibition of Platelet Adhesion and Aggregation by a Defined Region (Gly-486-Lys-502) of High Molecular Weight Kininogen J. Biol. Chem., June 21, 2002; 277(26): 23157 - 23164. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. CHAVAKIS, S. M. KANSE, R. A. PIXLEY, A. E. MAY, I. ISORDIA-SALAS, R. W. COLMAN, and K. T. PREISSNER Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen FASEB J, November 1, 2001; 15(13): 2365 - 2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mattsson, H. Herwald, H. Cramer, K. Persson, U. Sjobring, and L. Bjorck Staphylococcus aureus Induces Release of Bradykinin in Human Plasma Infect. Immun., June 1, 2001; 69(6): 3877 - 3882. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, Q. Qiu, F. Mahdi, Z. Shariat-Madar, R. Rojkjar, and A. H. Schmaier Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1821 - H1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chavakis, S. M. Kanse, F. Lupu, H.-P. Hammes, W. Muller-Esterl, R. A. Pixley, R. W. Colman, and K. T. Preissner Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions Blood, July 15, 2000; 96(2): 514 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Colman, B. A. Jameson, Y. Lin, D. Johnson, and S. A. Mousa Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis Blood, January 15, 2000; 95(2): 543 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. L. Yung, R. W. Colman, and S. L. Cooper Neutrophil Adhesion on Polyurethanes Preadsorbed With High Molecular Weight Kininogen Blood, October 15, 1999; 94(8): 2716 - 2724. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. H. Khan, S. P. Kunapuli, Y. Lin, A. Majluf-Cruz, R. A. D. Cadena, S. L. Cooper, and R. W. Colman Three noncontiguous peptides comprise binding sites on high-molecular-weight kininogen to neutrophils Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H145 - H150. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-X. Qin, K. J. Coyne, and J. H. Waite Tough Tendons. MUSSEL BYSSUS HAS COLLAGEN WITH SILK-LIKE DOMAINS J. Biol. Chem., December 19, 1997; 272(51): 32623 - 32627. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Colman and A. H. Schmaier Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes Blood, November 15, 1997; 90(10): 3819 - 3843. [Full Text] [PDF] |
||||
![]() |
K. J. Coyne, X. Qin, and J. H. Waite Extensible Collagen in Mussel Byssus: A Natural Block Copolymer Science, September 19, 1997; 277(5333): 1830 - 1832. [Abstract] [Full Text] |
||||
![]() |
A. A. K. Hasan, D. B. Cines, H. Herwald, A. H. Schmaier, and W. Müller-Esterl Mapping the Cell Binding Site on High Molecular Weight Kininogen Domain 5 J. Biol. Chem., August 18, 1995; 270(33): 19256 - 19261. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Ho, K. Badellino, F. A. Baglia, M.-F. Sun, M.-M. Zhao, D. Gailani, and P. N. Walsh The Role of High Molecular Weight Kininogen and Prothrombin as Cofactors in the Binding of Factor XI A3 Domain to the Platelet Surface J. Biol. Chem., August 11, 2000; 275(33): 25139 - 25145. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |